• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS TOTAL T3 REAGENTS; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS TOTAL T3 REAGENTS; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE Back to Search Results
Catalog Number 33830
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 12/22/2023
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2024 the customer reported obtaining erroneously elevated total t3 results for one patient involving the laboratory's access 2 immunoassay analyzer (serial number (b)(6).The customer provided the following results (the total t3 customer reference ranges are 0.87-1.78 ng/ml).The first questioned sample total t3 result for this patient was 2.37 ng/ml on (b)(6) 2023.This sample was tested on an alternate instrument with a result at 0.64 (unit not provided).Sample 2 total t3 result was 3.05 ng/ml on (b)(60 2024.This sample was tested on an alternate instrument with a result at 0.84 (unit not provided).Sample 3 total t3 result was 2.43 ng/ml on (b)(6) 2024.This sample was tested on an alternate instrument with a result at 0.37 (unit not provided).Sample 4 total t3 result was 1.86 ng/ml on (b)(6) 2024.This sample 4 was tested using heterophile blocking tube with a total t3 result at 1.89 ng/ml.This sample was also tested on an alternate instrument with a result at 0.52 (unit not provided).The sample 5 result was not questioned: total t3 result was 0.8 ng/ml on (b)(6) 2024.This sample 5 was tested on an alternate instrument with a result at 0.75 (unit not provided).Sample 6 total t3 result was 2.53 ng/ml on (b)(6) 2024.This sample 6 was tested using heterophile blocking tube with a total t3 result at 2.6 ng/ml.This sample was also tested on an alternate instrument with a result at 0.856 (unit not provided).The customer reported a delay in patient treatment.The customer reported that doctor looks at test results and prescribes medication on the same day.Due to the questioned results, patient samples are sent to an external testing laboratory and the results are provided one day later.No hardware errors were reported in conjunction with this event.Calibration passed on 20mar2024 with reagent lot 338710 and calibrator lot 338395.No quality control data was provided.Service was dispatched.Field service engineer (fse) changed reagent and calibration and used heterophile blocking tubes but the results were unchanged.No issues with samples integrity were reported by the customer.Note: the customer reported that the access free t4 results for this patient were also questioned.A second medwatch report will address the questioned access free t4 results for this patient.
 
Additional Manufacturer Narrative
A1: the full patient identifier is (b)(6).A2, a3, a4 and a5: the customer did not supply patient demographics such as age, date of birth, sex, weight, ethnicity or race.H3 and h6: the access total t3 reagent was not returned for evaluation.No hardware errors, flags were reported in conjunction with this event.No issues with samples integrity were reported by the customer.Service was dispatched.Field service engineer (fse) replaced reagent and calibrator pack.The fse also tested some samples using heterophile blocking tubes but the results were unchanged.In conclusion, the cause of this event cannot be determined with the available information.There is no evidence to reasonably suggest that a malfunction occurred in conjunction with this event.Note 1: a second medwatch report will address the questioned free t4 results for this patient.Note 2: a second patient with questioned free t4 and total t3 results was reported on (b)(6) 2024.Two other medwatch reports will address the questioned total t3 and free t4 results for this second patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS TOTAL T3 REAGENTS
Common Device Name
RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
angela vettel
250 s. kraemer blvd.
brea, CA 92821
7149613625
MDR Report Key19309599
Report Number2122870-2024-00019
Device Sequence Number11515622
Product Code CDP
UDI-Device Identifier15099590227210
UDI-Public(01)15099590227210(17)240930(11)231001(10)338848
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K973966
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 05/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/30/2024
Device Catalogue Number33830
Device Lot Number338848
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/21/2024
Initial Report FDA Received Date05/14/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/01/2023
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-